Kevin Bitterman, Director at Disc Medicine, Inc. (IRON), sold 54,496 shares at $79.95 ($4.4M) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($4.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.95 | 1 | $80 | 0.0% |
| 2 | $79.95 | 58 | $5K | 0.1% |
| 3 | $79.95 | 70 | $6K | 0.1% |
| 4 | $80.17 | 511 | $41K | 0.9% |
| 5 | $80.17 | 22,090 | $1.8M | 40.5% |
| 6 | $80.17 | 26,542 |
| $2.1M |
| 48.7% |
| 7 | $80.98 | 2 | $162 | 0.0% |
| 8 | $80.98 | 9 | $729 | 0.0% |
| 9 | $80.98 | 10 | $810 | 0.0% |
| 10 | $79.98 | 2,339 | $187K | 4.3% |
| 11 | $79.98 | 2,810 | $225K | 5.1% |
| 12 | $79.98 | 54 | $4K | 0.1% |
| Total | $80.15 avg | 54,496 | $4.4M | 100% |
| Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |
| IRON | SELL | 2025-10-17 | $12.3M | — | Filing → |